Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
- Title
- Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
- Author
- 배옥남
- Keywords
- Vascular endothelial growth factor (VEGF); Biomarker; Keratinocytic damage; Dermal toxicity; PERMEABILITY FACTOR; FACTOR EXPRESSION; ULTRAVIOLET-B; VEGF-C; EPIDERMAL-KERATINOCYTES; ATOPIC-DERMATITIS; FACTOR-ALPHA; FACTOR GENE; CULTURED KERATINOCYTES; HACAT KERATINOCYTES
- Issue Date
- 2015-01
- Publisher
- KOREAN SOC APPLIED PHARMACOLOGY
- Citation
- BIOMOLECULES & THERAPEUTICS, v. 23, No. 1, Page. 12-18
- Abstract
- Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.
- URI
- http://www.biomolther.org/journal/view.html?volume=23&number=1&spage=12&year=2015https://repository.hanyang.ac.kr/handle/20.500.11754/100629
- ISSN
- 1976-9148; 2005-4483
- DOI
- 10.4062/biomolther.2014.102
- Appears in Collections:
- COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML